Dehydroabiethylamine

Cat. No.: 0225LY-0741

Appearance: Solid

Purity: ≥98%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Dehydroabiethylamine acts as an inducer of CYP2B activity in the liver and functions as an anti-tumor agent by inhibiting intracellular cholesterol transport and pyruvate dehydrogenase kinases (PDKs).

Synonym: 1446-61-3; Leelamine; (+)-Dehydroabietylamine; ((1R,4aS,10aR)-7-Isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methanamine; 1-Phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R,4aS,10aR)-; 13-Isopropylpodocarpa-8,11,13-trien-15-amine; 1-Phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R-(1alpha,4abeta,10aalpha))-

CAS No.: 1446-61-3

Compound CID: 62034

Formula: C₂₀H₃₁

Formula Weight: 285.47

Specification

Relative Density: 0.963 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Dehydroabiethylamine can be used in chemical synthesis research or play an important role in studies concerning chiral resolution and natural product modification.